Kausik K Ray

Kausik K Ray

UNVERIFIED PROFILE

Are you Kausik K Ray?   Register this Author

Register author
Kausik K Ray

Kausik K Ray

Publications by authors named "Kausik K Ray"

Are you Kausik K Ray?   Register this Author

100Publications

3296Reads

48Profile Views

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.

Eur J Prev Cardiol 2019 Jul 29:2047487319864671. Epub 2019 Jul 29.

9 Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487319864671DOI Listing
July 2019

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Cardiovasc Diabetol 2019 Jun 4;18(1):71. Epub 2019 Jun 4.

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12933-019-0864-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549355PMC
June 2019

Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment.

J Am Coll Cardiol 2019 May;73(19):2451-2453

Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.02.058DOI Listing
May 2019

The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes.

Diabetes Obes Metab 2019 Apr;21 Suppl 1:6-16

Department of Primary Care and Public Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13691DOI Listing
April 2019

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.

N Engl J Med 2019 03;380(11):1022-1032

From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.); the Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY (H.E.B.); the University of Milan and Multimedica IRCCS, Milan (A.L.C.); Esperion Therapeutics, Ann Arbor, MI (N.D.L., L.T.B., L.R.S., P.L.R.); and Baylor College of Medicine, Houston (C.M.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1803917DOI Listing
March 2019

Mendelian Randomization Study of and Cardiovascular Disease.

N Engl J Med 2019 03;380(11):1033-1042

From the Centre for Naturally Randomized Trials (B.A.F., T.B.F.), Medical Research Council, British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care (B.A.F., S.B., C.O.-W., A.M.W., A.S.B., E.D.A., J.D.), Medical Research Council Biostatistics Unit (S.B.), and NIHR Blood and Transplant Research Unit in Donor Health and Genomics (A.S.B., E.D.A., J.D.), University of Cambridge, Cambridge, and Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London (K.K.R.) - all in the United Kingdom; the Department of Pharmacologic and Biomolecular Sciences, University of Milan and Multimedica IRCCS, Milan (A.L.C.); Michigan State University, East Lansing (D.R.N.); the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam (J.J.P.K.); and Monash University, Clayton, VIC, Australia (S.J.N.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1806747
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1806747DOI Listing
March 2019

Cholesterol-Lowering Agents.

Circ Res 2019 Feb;124(3):354-363

From the Department of Primary Care and Public Health, Imperial College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.118.313245DOI Listing
February 2019

Lp(a) and cardiovascular disease-Has the phoenix finally risen from the ashes?

Eur Heart J 2019 Feb 19. Epub 2019 Feb 19.

Department of Primary Care Public Health, Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, St Dunstan's Road, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz016DOI Listing
February 2019

Ethnicity-specific association of BMI levels at diagnosis of type 2 diabetes with cardiovascular disease and all-cause mortality risk.

Acta Diabetol 2019 Jan 30;56(1):87-96. Epub 2018 Aug 30.

Melbourne EpiCentre, University of Melbourne and Melbourne Health, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00592-018-1219-7DOI Listing
January 2019

Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial.

Diabetes Care 2019 01 28;42(1):173-176. Epub 2018 Nov 28.

Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College London, London, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc18-1491DOI Listing
January 2019

Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries.

Front Cardiovasc Med 2018 29;5:199. Epub 2019 Jan 29.

Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fcvm.2018.00199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361748PMC
January 2019

Improving the global care of familial hypercholesterolaemia: Starting the ball rolling.

Atherosclerosis 2018 10;277:230-233

School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia; Lipid Disorders Clinic, Cardiometabolic Services, Department of Cardiology, Royal Perth Hospital, Perth, Australia; Familial Hypercholesterolaemia Australasia Network, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00219150183136
Publisher Site
http://dx.doi.org/10.1016/j.atherosclerosis.2018.09.002DOI Listing
October 2018

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

Atherosclerosis 2018 10;277:234-255

Imperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.08.051DOI Listing
October 2018

Epidemiology of familial hypercholesterolaemia: Community and clinical.

Atherosclerosis 2018 10;277:289-297

Imperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00219150183113
Publisher Site
http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.855DOI Listing
October 2018

Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.

Atherosclerosis 2018 10;277:470-476

School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Cardiometabolic Services, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.822DOI Listing
October 2018

Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins.

Circulation 2018 Sep;138(13):1304-1316

Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, the Netherlands (R.M.S., J.J.P.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.034710DOI Listing
September 2018

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.

Circulation 2018 Aug;138(8):770-781

Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032318DOI Listing
August 2018

Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.

Atherosclerosis 2018 08 4;275:434-443. Epub 2018 Jun 4.

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.047DOI Listing
August 2018

'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies.

Eur Heart J 2018 Jul;39(27):2546-2550

Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Faculty of Medicine, Imperial College London, Level 2, Faculty Building, South Kensington Campus, London SW7 2AZ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehx710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047410PMC
July 2018

Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?

Diabetes Obes Metab 2018 06 11;20(6):1337-1341. Epub 2018 Mar 11.

Department of Primary Care and Public Health, Centre for Cardiovascular Disease Prevention, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13243DOI Listing
June 2018

Advances in lipid-lowering therapy through gene-silencing technologies.

Nat Rev Cardiol 2018 05 8;15(5):261-272. Epub 2018 Feb 8.

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsveg 3B, 2200 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrcardio.2018.3
Publisher Site
http://dx.doi.org/10.1038/nrcardio.2018.3DOI Listing
May 2018

Lipids and Lipoproteins in Risk Prediction.

Cardiol Clin 2018 May;36(2):213-220

Department of Primary Care and Public Health, School of Public Health, Imperial College, Imperial Centre for Cardiovascular Disease Prevention, Reynolds Building, St. Dunstan's Road, London W6 8RP, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccl.2017.12.002DOI Listing
May 2018

Inclisiran for the treatment of dyslipidemia.

Expert Opin Investig Drugs 2018 Mar 22;27(3):287-294. Epub 2018 Feb 22.

a Imperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health , School of Public Health, Imperial College London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1442435DOI Listing
March 2018

Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.

Diabetes Obes Metab 2017 12 10;19(12):1781-1792. Epub 2017 Oct 10.

University of California San Diego School of Medicine, and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698740PMC
December 2017

PCSK9 inhibition and atherosclerotic cardiovascular disease prevention: does reality match the hype?

Heart 2017 11 8;103(21):1670-1679. Epub 2017 Jun 8.

Department of Primary Care and Public Health, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2016-310844DOI Listing
November 2017

Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans.

Lipids Health Dis 2017 Oct 4;16(1):192. Epub 2017 Oct 4.

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12944-017-0571-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628497PMC
October 2017

Prediction of cardiovascular risk in patients with familial hypercholesterolaemia.

Eur Heart J Qual Care Clin Outcomes 2017 10;3(4):274-280

Endocrinology - Metabolism and Prevention of Cardiovascular Diseases, Hôpital Pitié Salpêtrière, 47-83 Boulevard de l'Hôpital, Paris, 75651, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjqcco/qcx011DOI Listing
October 2017

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Nutr Rev 2017 Sep;75(9):731-767

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland; Polish Mother's Memorial Hospital Research Institute, Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland; Lipid and Blood Pressure Meta-Analysis Collaboration Group; and Polish Lipid Association.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nutrit/nux047DOI Listing
September 2017

The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta-analysis of randomized controlled trials.

Pharmacol Res 2017 Aug 9;122:105-117. Epub 2017 Jun 9.

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland; Polish Mother's Memorial Hospital Research Institute, Lodz, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2017.06.002DOI Listing
August 2017

Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management.

Atherosclerosis 2017 Aug 3;263:112-118. Epub 2017 Jun 3.

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.006DOI Listing
August 2017

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Arch Med Sci 2017 Aug 4;13(5):965-1005. Epub 2017 Aug 4.

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland; Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group; Polish Lipid Association (PoLA).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/aoms.2017.69326DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575230PMC
August 2017

Relation of Fasting Triglyceride-Rich Lipoprotein Cholesterol to Coronary Artery Calcium Score (from the ELSA-Brasil Study).

Am J Cardiol 2017 05 10;119(9):1352-1358. Epub 2017 Feb 10.

Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo School of Medicine, São Paulo, Brazil; University of São Paulo School of Medicine, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2017.01.033DOI Listing
May 2017

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.

N Engl J Med 2017 04 17;376(15):1430-1440. Epub 2017 Mar 17.

From the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.), and Knowle House Surgery, Plymouth (T.H.) - both in the United Kingdom; the Department of Cardiology, Charité-Universitätsmedizin Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Berlin (U.L.), and University Heart Center Hamburg, Department of General and Interventional Cardiology, Hamburg (M.K.) - all in Germany; the Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Medicines Company, Parsippany, NJ (D.K., P.W.); Institut de Recherches Cliniques de Montréal, University of Montreal, Montreal (R.D.); the Department of Cardiology and Interventional Cardiology, VieCuri Medical Center for Northern Limburg, Venlo (R.P.T.T.), University Medical Center, Utrecht (F.L.J.V.), and the Department of Vascular Medicine, Academic Medical Center-University of Amsterdam, Amsterdam (J.J.P.K.) - all in the Netherlands; the Metabolic and Atherosclerosis Research Center, Medpace, Cincinnati (T.T.); and the Department of Cardiology, Mayo Clinic, Rochester, MN (R.S.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615758DOI Listing
April 2017

Will genetic studies deliver the next generation of cardioprotective therapies?

Eur J Prev Cardiol 2017 03 25;24(5):489-491. Epub 2017 Jan 25.

3 Julius Center for Health Sciences and Primary Care and Julius Clinical Research, University Medical Center Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487317690960DOI Listing
March 2017

Time to change the SCORE?

Eur Heart J 2017 02;38(8):595-597

Department of Vascular Medicine, Academic Medical Center, University of AmsterdamAmsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw428DOI Listing
February 2017

The need for a new classification of cholesterol lowering therapies.

Curr Med Res Opin 2017 01 3;33(1):67-69. Epub 2016 Oct 3.

c Department of Primary Care and Public Health , School of Public Health, Imperial College London , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2016.1233102DOI Listing
January 2017

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.

Diabetes Care 2017 Jan 17;40(1):69-76. Epub 2016 Oct 17.

Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-0621DOI Listing
January 2017

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control.

Circulation 2016 Dec 24;134(24):1931-1943. Epub 2016 Oct 24.

From Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK (K.K.R.); Columbia University, New York, NY (H.N.G.); Department of Medicine, University of Chicago Medicine, Chicago, IL (M.H.D.); Regeneron Pharmaceuticals, Inc Tarrytown, NY (R.P.); Sanofi, Paris, France (L.B.); Biostatistics and Programming, Sanofi, Chilly-Mazarin, France (P.M.); University of Colorado, Anschutz Medical Campus, Aurora (R.H.E.); and Harvard Clinical Research Institute, Boston, MA (C.P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147039PMC
December 2016

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

Atheroscler Suppl 2016 Dec 7;22:1-32. Epub 2016 Dec 7.

Imperial Centre for Cardiovascular Disease Prevention (ICCP), School of Public Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosissup.2016.10.001DOI Listing
December 2016

Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.

Circulation 2016 Nov 28;134(19):1419-1429. Epub 2016 Sep 28.

From Department of Vascular Medicine (L.K., J.W., F.L.J.V.), Julius Centre for Health Sciences and Primary Care (Y.v.d.G.), Department of Cardiology (M.J.M.C.), Department of Neurology (L.J.K.), and Department of Vascular Surgery (G.J.d.B.), University Medical Centre Utrecht, the Netherlands; Departments of Cardiology (S.M.B., R.J.G.P.) and Vascular Medicine (J.J.P.K.), Academic Medical Centre, Amsterdam, the Netherlands; School of Public Health, Imperial College London, United Kingdom (K.K.R.); Department of Neurology and Stroke Center, Bichat University Hospital, Paris, France (P.A.); and SUNY Health Science Center at Brooklyn, New York, NY (J.C.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021314DOI Listing
November 2016

Diabetic microvascular triopathy, smoking, and risk of cardiovascular events - Author's reply.

Lancet Diabetes Endocrinol 2016 11;4(11):888-889

Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)30262-5DOI Listing
November 2016

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.

Atherosclerosis 2016 10 15;253:194-208. Epub 2016 Jul 15.

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland; Healthy Aging Research Centre (HARC), Lodz, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.897DOI Listing
October 2016

Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.

Pharmacol Res 2016 09 15;111:163-179. Epub 2016 Jun 15.

Geriatric Department, Campus Bio-Medico University and Teaching Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2016.06.011DOI Listing
September 2016

Where to now in cardiovascular disease prevention.

Atherosclerosis 2016 08 18;251:483-489. Epub 2016 Jun 18.

Department of Primary Care and Public Health, The Reynolds Building, Imperial College London, St Dunstan's Road, London, W6 8RP, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2016.06.036DOI Listing
August 2016

Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1. A systematic review and meta-analysis of randomised controlled trials.

Thromb Haemost 2016 07 24;116(1):162-71. Epub 2016 Mar 24.

GianLuca Colussi, MD, Clinica Medica, University of Udine, University Hospital, Building 8, 1st floor, 33100 Udine, Italy, Tel.: +39 0432 559 804, Fax: +39 0432 559 490, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-10-0770DOI Listing
July 2016

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study.

Lancet Diabetes Endocrinol 2016 07 20;4(7):588-97. Epub 2016 May 20.

Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)30057-2DOI Listing
July 2016

Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature.

Clin Ther 2016 Jul 31;38(7):1696-709. Epub 2016 May 31.

Hôpital Pitié Salpêtrière, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2016.05.006DOI Listing
July 2016

Familial hypercholesterolaemia: a common disease.

Eur Heart J 2016 05 18;37(17):1395-7. Epub 2016 Apr 18.

Department of Vascular Medicine, Academic Medical Center, AZ Amsterdam, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw130DOI Listing
May 2016

Promoting high-density lipoprotein function via intravenous infusion: the rebirth of apoA-I Milano?

Eur Heart J Cardiovasc Pharmacother 2016 01 10;2(1):30-1. Epub 2015 Dec 10.

Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, Reynolds building, St Dunstan's road, W6 8RP, London, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjcvp/pvv042DOI Listing
January 2016

New Approaches in Detection and Treatment of Familial Hypercholesterolemia.

Curr Cardiol Rep 2015 Dec;17(12):109

Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11886-015-0665-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611021PMC
December 2015

Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.

Thromb Haemost 2015 Aug 28;114(3):546-57. Epub 2015 May 28.

Prof. Maciej Banach, MD, PhD, FNLA, FAHA, FESC; FASA, Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113; 90-549 Lodz, Poland, Tel.: +48 42 639 37 71, Fax: +48 42 639 37 71, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH14-11-0937DOI Listing
August 2015

The evolving role of CETP inhibition: beyond HDL cholesterol.

Lancet 2015 Aug 2;386(9992):412-4. Epub 2015 Jun 2.

Cardiovascular Sciences, Cardiovascular and Cell Sciences Research Institute, St George's University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60608-0DOI Listing
August 2015

Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials.

Atherosclerosis 2015 Aug 3;241(2):433-42. Epub 2015 Jun 3.

Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2015.05.022DOI Listing
August 2015

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief?

Circulation 2015 Aug;132(5):433-40

From Department of Vascular Medicine (G.K.H.) and Department of Cardiology (S.M.B.), Academic Medical Center, Amsterdam, The Netherlands; and Department of Primary Care and Public Health, School of Public Health, Imperial College, London, United Kingdom (K.K.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.014026DOI Listing
August 2015

Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.

Atherosclerosis 2015 Jul 30;241(1):62-8. Epub 2015 Apr 30.

Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.810DOI Listing
July 2015

New worldwide lipid guidelines.

Curr Opin Cardiol 2015 Jul;30(4):447-53

aSouth London Healthcare NHS Trust bDepartment of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0000000000000184DOI Listing
July 2015

Cholesterol efflux capacity as a novel biomarker for incident cardiovascular events: has high-density lipoprotein been resuscitated?

Circ Res 2015 May;116(10):1646-8

From the Cardiovascular Sciences Department, Cardiovascular and Cell Sciences Research Institute, St George's University of London, London, UK (A.J.V.V.); and Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK (K.K.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCRESAHA.115.305938DOI Listing
May 2015

Cardiac rehabilitation versus standard care after aortic aneurysm repair (Aneurysm CaRe): study protocol for a randomised controlled trial.

Trials 2015 Apr 15;16:162. Epub 2015 Apr 15.

Department of Outcomes Research, St George's Vascular Institute, St George's Healthcare NHS Trust, Room 4.007, Blackshaw Road, London, SW17 0QT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-015-0669-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407427PMC
April 2015